McCormick & Company is rated a buy with a 35% upside to a $65 price target, driven by its transformative acquisition of Unilever Foods and a strong 4% dividend yield. Although Q2 results were underwhelming due to weakness in the Americas Consumer segment, the company's valuation is at a ten-year low, reflecting current challenges. The Unilever deal is expected to boost earnings per share by mid to high single digits in the first year and mid to high teens by year three, offering significant scale and geographic diversification. Key risks include integration difficulties, higher leverage, and ongoing consumer softness, but plans for deleveraging and synergy updates are anticipated in upcoming quarters.
McCormick reported a 16.7% increase in net sales for Q2, driven mainly by acquisitions and favorable currency effects, while organic growth stayed weak. The company's gross margin improved by 270 basis points to 40.2%, supported by acquisitions, pric...
McCormick & Company reported fiscal Q2 2026 earnings of $0.80 per share, beating analyst estimates of $0.70, with revenue of $1.94 billion surpassing expectations. Net sales grew 16.7% year-over-year, boosted by currency effects and the McCormick de ...
McCormick & Company posted a 16.7% increase in net sales for Q2 2026, driven by acquisitions and organic growth, with adjusted operating income up 30%. The company reaffirmed its 2026 outlook, expecting continued sales and earnings growth supported b...
McCormick & Company announced a quarterly dividend of $0.48 per share, payable on July 20, 2026, to shareholders of record as of July 6, 2026. This dividend continues the company's impressive streak of 102 consecutive years of dividend payments. McCo...
